After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...

Are memory lapses a result of normal aging or symptoms of something more serious? Then, a closer look at a new device ...

According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...